Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FVC”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Looking for participantsNCT06967805
What this trial is testing

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Mediar Therapeutics 164
Testing effectiveness (Phase 2)Study completedNCT00514683
What this trial is testing

Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 432
Post-approval studies (Phase 4)Study completedNCT01999075
What this trial is testing

Stacking Exercises Aid the Decline in FVC and Sick Time

Who this might be right for
Duchenne Muscular Dystrophy
Children's Hospital of Eastern Ontario 70
Not applicableStudy completedNCT02151435
What this trial is testing

Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis

Who this might be right for
IPF
University of Michigan 43
Not applicableUnknownNCT05145088
What this trial is testing

Association Analysis of Aerobic Capacity and Expiratory Forced Vital Capacity in Overweight and Obese Adults After Submaximal Exercise Training of Three Weeks

Who this might be right for
Overweight and Obese Adults
Foundation University Islamabad 30
Testing effectiveness (Phase 2)Study completedNCT00785083
What this trial is testing

The Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

Who this might be right for
Asthma
Novartis 36
Not applicableUnknownNCT06530056
What this trial is testing

Costovertebral Mobilization on Kyphotic Posture and Lung Function in Non-Smoker

Who this might be right for
Hyperkypohsis and Impaired Lung Function
Riphah International University 44
Not applicableStudy completedNCT04307316
What this trial is testing

Effects of ACBT on Pulmonary Function After CABG During Phase 1 Cardiac Rehabilitation

Who this might be right for
Coronary Artery Bypass Graft Surgery
Riphah International University 40
Large-scale testing (Phase 3)Looking for participantsNCT06440746
What this trial is testing

Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases

Who this might be right for
Lung Diseases, Interstitial
R-Pharm International, LLC 138
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Post-approval studies (Phase 4)Study completedNCT00706277
What this trial is testing

Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function

Who this might be right for
Lung Function
Medical University Innsbruck 60
Not applicableStudy completedNCT06608602
What this trial is testing

Tidal Volume Adjustment According to Forced Vital Capacity Versus Predicted Body Weight in Thoracic Surgery Patients

Who this might be right for
Thoracic SurgeryTidal VolumeForced Vital Capacity+1 more
Cukurova University 140
Testing effectiveness (Phase 2)Ended earlyNCT05497284
What this trial is testing

To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 46
Early research (Phase 1)Study completedNCT01640067
What this trial is testing

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliera Santa Maria, Terni, Italy 18
Not applicableStudy completedNCT03396120
What this trial is testing

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseasePulmonary Hypertension
Assiut University 95
Not applicableStudy completedNCT01048021
What this trial is testing

Pulmonary Function Changes and Diaphragmatic Paralysis Following Ultrasound Guided Supraclavicular Brachial Plexus Blockade: The Effects of Decreased Local Anesthetic Volume

Who this might be right for
Diaphragmatic FunctionLung Function
University of Manitoba 30
Testing effectiveness (Phase 2)Looking for participantsNCT06470048
What this trial is testing

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)UnknownNCT01131806
What this trial is testing

Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Taipei Veterans General Hospital, Taiwan 124
Not applicableStudy completedNCT04716166
What this trial is testing

Incentive Spirometry and Upper Abdominal Laparoscopic Surgery

Who this might be right for
CholecystitisPerforated Duodenal UlcerDiaphragmatic Hernia+6 more
Riphah International University 60
Testing effectiveness (Phase 2)Ended earlyNCT05626751
What this trial is testing

An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 174
Next Page